Gabapentin Capsule
Product Images NDC 31722-149

9 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 31722-149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation (Equation)

Equation (Equation)
Formula for calculating creatinine clearance (ClCr) using age, weight, and serum creatinine, with an adjustment factor for female patients. This formula is presented as part of the drug information for gabapentin capsules by Camber Pharmaceuticals.*
FDA Label Image

Structure (Struct)

Structure (Struct)
Chemical structure diagram of gabapentin showing a cyclohexane ring bonded to an amino group and a carboxymethyl group, representing the molecular structure of the active ingredient gabapentin.*
FDA Label Image

Fig 1 (Fig 1)

Fig 1 (Fig 1)
A line graph depicting weekly mean pain scores over an 8-week period comparing placebo and gabapentin 3600 mg/day treatments. The x-axis represents weeks, while the y-axis shows the mean pain score. Gabapentin shows a decreasing trend in pain scores compared to placebo.*
FDA Label Image

Fig 2 (Fig 2)

Fig 2 (Fig 2)
A line graph showing weekly mean pain scores over 7 weeks from a clinical study. The x-axis represents weeks, including baseline, weeks 1 to 7, and the y-axis represents mean pain scores from 0 to 10. Three groups are plotted: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day, showing pain score trends over time.*
FDA Label Image

Fig 3 (Fig 3)

Fig 3 (Fig 3)
A bar chart titled "Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies". It compares the percentage of responders for placebo (PBO) and gabapentin (GBP) at different dosages across two studies. Study 1 shows 12% for placebo and 29% for GBP 3600 mg. Study 2 shows 14% for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance is indicated for gabapentin doses.*
FDA Label Image

Fig 4 (Fig 4)

Fig 4 (Fig 4)
A scatter plot chart showing responder rate differences (%) from placebo by daily gabapentin dose (mg) across three studies labeled a, b, and c. The x-axis represents daily dose from 600 to 1800 mg, and the y-axis shows difference percentages from 2% to 22%. Study a is represented by black squares, study b by gray squares, and study c by white squares, with data points indicating variability in response rates at different dose levels.*
FDA Label Image

100mg-500count (100mg 500count)

100mg-500count (100mg 500count)
Gabapentin Capsules, USP 100 mg oral capsules in a 500-count container. The label includes the NDC 31722-148-05 and states the product is manufactured by Ascent Pharmaceuticals, Inc., and labeled by Camber Pharmaceuticals, Inc. Storage instructions are for 25°C with excursions permitted between 15° to 30°C. The label instructs pharmacists to dispense the Medication Guide separately and notes Rx-only status.*
FDA Label Image

300mg-500count (300mg 500count)

300mg-500count (300mg 500count)
Label for Gabapentin Capsules, USP 300 mg by Camber Pharmaceuticals, Inc. The label indicates a package of 500 capsules, with storage instructions, dosage and use information referencing the package insert, and manufacturer details for Ascent Pharmaceuticals, Inc. and Camber Pharmaceuticals, Inc.*
FDA Label Image

400mg-500count (400mg 500count)

400mg-500count (400mg 500count)
The label of Gabapentin Capsules, USP 400 mg by Camber Pharmaceuticals, Inc. It includes the NDC 31722-150-05 and indicates the package contains 500 capsules. Storage instructions specify 25°C with permitted excursions. The label advises dispensing with the Medication Guide and provides manufacturing information for Ascent Pharmaceuticals and Camber Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.